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Background: Epidemiological studies and feeding trials
with supplements suggest that fibre intake is associated
with a reduction in cardiovascular risk. However, the
effects of changes in dietary fibre on risk factor levels
have not been evaluated in free-living individuals. Thus,
the effects of changes in dietary fibre intake on
cardiovascular risk factors were assessed over 3 months
in free-living high-risk subjects.
Methods: 772 high-risk subjects (age 69¡5 years) were
assigned to a low-fat diet or two Mediterranean-style
diets. All participants received behavioural and nutritional
education, including recommendations for increasing the
consumption of vegetables, fruits, and legumes. Changes
in food and nutrient intake, body weight, blood pressure,
lipid profiles, glucose control and inflammatory markers
were evaluated.
Results: Most participants increased consumption of
vegetable products, but the increase in dietary fibre
exhibited wide between-subject variability (6–65 g/day).
Body weight, waist circumference, and mean systolic and
diastolic blood pressure decreased across quintiles of
fibre intake (p,0.005; all). Reductions in fasting glucose
and total cholesterol levels, and increments in HDL
cholesterol were highest among participants in the upper
20% of fibre intake (p = 0.04 and 0.02 respectively).
Plasma concentrations of C-reactive protein, but not those
of inflammatory cytokines, decreased in parallel with
increasing dietary fibre (p = 0.04). Significant reductions
in LDL cholesterol were observed only among participants
with the greatest increases in soluble fibre intake
(p = 0.04).
Conclusions: Increasing dietary fibre intake with natural
foods is associated with reductions in classical and novel
cardiovascular risk factors in a high-risk cohort.
The Mediterranean diet (Med-diet) has been
widely considered as a model of healthy eating.
This dietary pattern is characterised by a high
consumption of non-refined grains, legumes, nuts,
fruits and vegetables; relatively high intake of total
fat, mainly derived from olive oil; moderate to high
intake of fish and poultry; dairy products (usually
as yogurt or cheese) in small amounts; low
consumption of red meat and meat products; and
moderate alcohol intake, usually in the form of red
wine with meals.1 Thus, high consumption of
fibre-rich foods is one of the characteristic features
of the Med-diet.
Dietary fibre (DF), a mixture of chemicals in
indigestible vegetable residues,2 has received much
attention in nutritional epidemiology. Observa-
tional studies have consistently shown that DF
intake is associated with reduced cardiovascular
risk, including ischaemic heart disease3–6 and
stroke,5–8 and lower risk of diabetes.9–11 Clinical
trials have also suggested that DF supplementation
has beneficial effects on risk factors, such as blood
pressure, serum lipids, insulin sensitivity and
diabetic metabolic control.12–16 However, no inter-
vention study has evaluated the effects of DF on
classical and novel risk factors in free-living persons
at high cardiovascular risk.
To address this issue, the effects of 3-month
changes in DF intake on cardiovascular risk factors
were evaluated in a large sample of subjects at high
risk for cardiovascular disease.
METHODS
Study design
The PREDIMED study (PREvencio´n con DIeta
MEDiterra´nea) is a large multi-centre, randomised
5-year clinical trial aimed at assessing the effects of
the Med-diet on the primary prevention of
cardiovascular disease (CVD) in Spain (http://
www.predimed.org). Up to September 2008, this
trial includes 6988 high-risk participants allocated
to three interventions: Med-diet plus virgin oil,
Med-diet plus nuts and control diet (low-fat diet).
The main outcome for the whole trial is an
aggregate of cardiovascular events (cardiovascular
death, non-fatal myocardial infarction or non-fatal
stroke). The Institutional Review Boards of the
participating centres approved the study protocol.
This trial has been registered with the
International Standard Randomised Controlled
Trial Number (ISRCTN) 35739639. The trial
design has been described in detail elsewhere.17
The present study was designed as a short-term
trial in a subset of participants, namely those
entering the PREDIMED trial during the first
6 months of recruitment, to assess the effects of
changes in dietary fibre intake on surrogate
markers of atherosclerosis.
Participants and recruitment
Nine-hundred and thirty possible participants were
evaluated. Eligible subjects were community-dwell-
ing persons, aged 55–80 years for men and 60–80
years for women, who had either type 2 diabetes or
three or more of the following CHD risk factors:
current smoking, hypertension (blood pressure.
140/90 mmHg), LDL cholesterol >160 mg/dl, low
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HDL cholesterol ((40 mg/dl), body mass index (BMI>25 kg/
m2), or family history of premature CHD. Exclusion criteria were:
previous history of cardiovascular disease, any severe chronic
illness, illegal drug use or alcoholism, and low predicted likelihood
of changing dietary habits.18
The primary care physicians based participants’ eligibility on
review of clinical records and a screening visit. Suitable
candidates were invited to attend a screening visit. This
included a face-to-face interview to inquire about medical
conditions and risk factors related to eligibility. More than 95%
of eligible candidates who met entry requirements signed an
informed consent and agreed to return for the baseline visit.
Baseline assessment and intervention
A validated 137-item food frequency questionnaire (FFQ),19 and
the validated Spanish version20 of the Minnesota Leisure Time
Physical Activity questionnaire were administered in the base-
line assessment. For each food included in the FFQ, a standard
portion size (representing the serving size of that item most
frequently consumed currently in Spain) was specified. Dietary
fibre intake was calculated by multiplying the frequency of
consumption of each item by the fibre content of the specified
serving, according to Spanish food composition tables.21 The
intra-class correlation coefficient comparing DF intake by FFQ
with the average of four 3-day dietary records was 0.75.
Anthropometric measurements, blood pressure, spot urine and
fasting blood samples were obtained. All examinations were
repeated at 3 months.
Trained dieticians were responsible for all aspects of the
interventions and assisted participants in completing the FFQ.22
Participants assigned to the control group received personal
advice together with a leaflet with written recommendations to
follow a low-fat diet.23 Participants in the two Med-diet
intervention groups were given personalized advice for dietary
changes directed to achieve a diet closest to the traditional Med-
diet.22 Depending on group assignment, participants were given
free virgin olive oil or free sachets of walnuts, hazelnuts and
almonds. In the three groups, the general guidelines included
positive recommendations for increased consumption of vege-
tables, fruits, legumes, fish and seafood, and white meats
instead of red meats. Negative recommendations included
limiting and/or eliminating presumed detrimental foods (red
and processed meats, fat-rich dairy products, commercial
pastries, snacks and sugar-sweetened beverages). Thus, all
intervention diets coincided in the recommendation to increase
fibre-rich foods, a reason why the three intervention groups are
grouped as a single one for the comparisons of fibre intake and
change in risk factor levels.
A 1-hour group session with up to 20 participants, with
separate sessions for each intervention group, was scheduled
after inclusion. Group sessions consisted of informative talks
and provision of written material with descriptions of main
foods, seasonal shopping lists, meal plans and cooking recipes.22
Measurements
Weight and height were measured with calibrated scales and a
wall-mounted stadiometer respectively. Waist circumference
was measured midway between the lowest rib and the iliac crest
using an anthropometric tape. Trained personnel measured
blood pressure in triplicate with a validated semi-automatic
oscillometer (Omron HEM-705CP, The Netherlands).
Blood and urine samples were obtained after an overnight
fast. Serum, EDTA- plasma, and urine samples were coded,
shipped to central laboratories and stored at 280uC until assay.
The clinical investigators and laboratory technicians were
blinded to intervention. Analyses determined by subject in
frozen samples of whole serum or plasma as appropriate were:
blood glucose by the glucose-oxidase method; serum insulin by
radioimmunoassay; cholesterol and triglycerides by enzymatic
procedures; HDL cholesterol after precipitation with phospho-
tungstic acid and magnesium chloride; soluble intercellular
adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-
1 (VCAM-1) and interleukin-6 (IL-6) by standard ELISA assays;
and high sensitivity C-reactive protein (CRP) by particle-
enhanced immunonephelometry.
Statistical analyses
For the comparison of changes in risk factors, the average of two
baseline measurements was used as the baseline value and the
average of the two 3-month measurements was used as the final
variable. Values with a skewed distribution (CRP, VCAM-1,
ICAM-1 and IL-6) were transformed to their natural logarithm
for analyses. Those subjects whose energy intake, as derived
from food frequency questionnaires, was outside pre-specified
ranges (2510–14 644 kJ for women and 3347–17 573 kJ for
men) were excluded from the calculations of energy and
nutrient intake, as recommended in nutritional epidemiology.24
Multiple linear regression models were used to study the
relationship between DF and changes in risk factors. Mean
differences in the changes of these variables (post-trial minus
pre-trial values) were compared by quintiles of change in DF
intake. Adjustments were made for intervention group, age,
gender, body weight, smoking, alcohol intake and physical
activity. The treatment effects are expressed as average changes
and 95% confidence intervals (CI).
RESULTS
Of the 930 eligible subjects, 158 were excluded for the following
reasons: not meeting inclusion criteria (n = 86), not accepting to
change their dietary habits (n = 18), excessive alcohol intake
(n = 14), gastrointestinal disease (n = 4), food allergies (n = 3) or
refusing to participate (n = 33). Table 1 shows the baseline
characteristics of the 772 participants (348 men and 424
women) who entered the study. Most of them were overweight
or obese (90%), more than three-quarters had hypertension,
one-quarter had family history of cardiovascular disease and
one-fifth were smokers. There were only three withdrawals
before study completion. The baseline data of these subjects
were similar to the mean values for the overall group.
Subsequent data refer only to the 769 participants who
completed the study.
Food, energy and nutrient intake
Forty-eight participants were excluded from food, energy and
nutrient calculations because they reported unrealistic energy
intakes.21 Following the advice of the dieticians, most of the
participants increased consumption of vegetables, legumes, fruits
and fish, and decreased intake of meat and dairy products
(table 2). Cereal intake also decreased due to reduced consump-
tion of white bread, which is the main cereal food in the Spanish
diet. A large increase in the consumption of nuts, one of the
supplemental foods given, was observed, whereas the total
amount of olive oil did not change because participants replaced
customarily used refined olive oil by the virgin variety supplied.
Alcohol intake increased slightly at the expense of wine, one of
the components of the Med-diet recommended in moderation to
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participants who were not abstainers at baseline. The results did
not materially change when the participants whose energy
consumption was out of range were included in the calculations.
Table 2 also shows 3-month changes in energy and nutrient
intake. The reduction from baseline in reported energy intake
was due to decreases in intake of carbohydrate and total fat,
whereas protein intake increased. Increases in intake of
monounsaturated fatty acids (MUFA) and polyunsaturated
fatty acids (PUFA), including both vegetable and marine n-3
fatty acids, and a decrease in saturated fatty acid (SFA) intake
occurred. Estimated energy expenditure from physical activity
was similar at baseline and after 3 months.
Fibre and vascular risk factors
A significant increase in total and soluble DF intake was
observed at the 3-month assessment (table 2). However, the
consumption of DF exhibited wide between-subject variability.
In fact, daily DF intake ranged from 6 to 65 g at the 3-month
assessment. Because energy and DF intake increased in parallel,
changes in DF intake categorised in quintiles were energy-
adjusted to assess associations with other variables (table 3).
Demographic characteristics, adiposity and cardiovascular risk
factors were similar across the range of DF intake. Predictably,
increasing DF intake was associated directly with carbohydrate
intake and inversely with intake of total fat, MUFA and SFA.
There were no differences in alcohol intake or sedentariness by
categories of DF intake.
Table 4 shows adjusted changes in risk factors according to
quintiles of change in DF. The higher the increment in DF
intake, the greater was the weight loss and the reduction in
waist circumference and systolic and diastolic blood pressure. In
addition, fasting glucose and total cholesterol levels decreased,
and HDL cholesterol increased with increasing DF intake.
Reductions in serum LDL cholesterol concentrations, but not in
triglycerides, were not significantly higher for participants with
greater increases in DF. The plasma levels of CRP, a systemic
biomarker of inflammation, but not those of other inflamma-
tory biomarkers, also decreased in parallel with increases in DF.
Table 1 Baseline characteristics of the 772 subjects included in the
study
Characteristics Participants
Age, mean (SD), years 68.8 (6.4)
Gender, men (%) 339 (44)
Family history of CHD, no. (%) 178 (23)
Current smokers, no. (%) 127 (16)
Type 2 diabetes mellitus, no. (%) 421 (54)
Hypertension, no (%) 605 (78)
Dyslipidaemia, no. (%) 515 (67)
Body mass index .25 kg/m2* 29.9 (4.2)
Overweight or obesity 696 (90)
Medications, no. (%)
ACE inhibitors 340 (44)
Diuretics 271 (35)
Other antihypertensive agents 160 (21)
Statins 326 (42)
Other lipid-lowering agents 51 (6)
Insulin 61 (8)
Oral hypoglycaemic drugs 282 (37)
Aspirin or other antiplatelet drugs 138 (18)
Occupation, no. (%)
Unskilled 179 (23)
Skilled manual 288 (37)
Skilled non-manual 172 (22)
Directive and professional 133 (17)
Education level, no. (%)
Primary school 554 (72)
First degree high school 126 (16)
High school or university 91 (12)
Abbreviations: CHD, coronary heart disease; ACE, angiotensin-converting enzyme.
*Calculated as weight in kilograms divided by the square of height in metres.
Table 2 Baseline levels and 3-month changes in the consumption of key food items, energy and nutrients
Variables Baseline 3 months Change, mean (95% CI) p Value
Foods, daily consumption in grams
Fruits 262 (218) 280 (153) 18.1 (0.4 to 35.7) 0.044
Vegetables 357 (168) 362 (164) 5.1 (28.0 to 18.2) 0.443
Legumes 14.3 (9.3) 19.5 (21.5) 5.2 (3.6 to 6.9) ,0.001
Fish, seafood 111 (63) 114 (87) 2.6 (23.6 to 8.8) 0.414
Meat, meat products 157 (75) 136 (58) 220.6 (226.6 to 215.2) ,0.001
Cereals 263 (124) 238 (115) 224.8 (234.4 to 215.2) ,0.001
Dairy products 403 (228) 387 (226) 216.1 (232.1 to 20.2) 0.047
Refined-mixed olive oil 20.5 (20.7) 13.6 (19.5) 26.9 (28.6 to 25.1) ,0.001
Virgin olive oil 19.9 (23.9) 27.6 (23.8) 7.7 (5.9 to 9.4) ,0.001
Total nuts 11.0 (16) 22.1 (23.5) 11.1 (9.1 to 13.1) ,0.001
Alcohol 10.5 (17.3) 12.3 (18.4) 1.9 (0.6 to 3.1) 0.003
Energy and nutrients
Energy, kj/d 2538 (738) 2393 (638) 2145 (2200 to 288) ,0.001
Protein, % En 17.1 (3.3) 18.8 (6.0) 1.7 (1.2 to 2.3) ,0.001
Carbohydrate, % En 41.9 (7.7) 41.0 (7.70) 20.9 (21.5 to 20.3) ,0.001
Total fibre, g/d 21.1 (7.6) 22.2 (7.9) 1.1 (0.4 to 1.7) 0.001
Soluble fibre, g/d 5.5 (2.1) 5.9 (2.0) 0.4 (0.2 to 0.6) ,0.001
Total fat, % En 38.2 (7.3) 37.2 (9.1) 20.8 (21.5 to 20.1) 0.020
MUFA 18.8 (4.6) 19.3 (4.6) 0.5 (0.1 to 0.8) 0.009
PUFA 6.8 (2.2) 7.2 (3.2) 1.0 (0.8 to 1.3) ,0.001
SFA 10.1 (2.4) 9.2 (2.2) 20.8 (21.0 to 20.7) ,0.001
Alpha-linolenic acid, g/d 1.5 (0.9) 1.9 (1.4) 0.4 (0.3 to 0.5) ,0.001
Marine n-3 fatty acids, g/d 0.8 (0.6) 0.9 (0.9) 0.1 (0.0 to 0.2) 0.009
CI, Confidence Interval; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids.
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Table 5 shows changes in cardiovascular risk factors between
extreme quintiles of DF intake. The differences were statisti-
cally significant for body weight, waist circumference, systolic
and diastolic blood pressure, fasting glucose and total choles-
terol. When the same analysis was performed for changes in
soluble DF intake, the results were similar, except for changes in
LDL cholesterol, which were 28.06 mg/dl (95% CI 15.83 to
22.87), significantly (p = 0.042) different between extreme
quintiles. Changes of cardiovascular risk factors in quintile 5
versus quintile 1 of DF intake ranged from nearly 1 kg reduction
in body weight to close to a 9 mm decrease in systolic blood
pressure.
DISCUSSION
The hypothesis that the provision of increasing amounts of DF
from natural foods might be instrumental in the effect of a
Mediterranean-style diet to reduce the levels of cardiovascular
risk factors was tested. The rationale underlying this substudy
of the PREDIMED feeding trial was the available epidemiolo-
gical and clinical trial evidence supporting the association of DF
intake with beneficial effects on surrogate markers of cardio-
metabolic risk, including systemic inflammation.12 14 25–27 In fact,
DF intake after a 3-month behavioural intervention to enhance
the Med-diet was associated with significant reductions in body
weight, waist circumference, systolic and diastolic blood
pressure and fasting glucose, as well as a greater increase in
HDL cholesterol. In addition, when changes in the consumption
of soluble DF were specifically assessed, participants in the
highest quintile also showed a significantly greater reduction in
serum LDL cholesterol concentration than those in the lowest
quintile.
Many epidemiological studies have evaluated the effects of
DF on the risk of coronary heart disease.3–6 In a pooled analysis
of 10 prospective cohorts,28 each 10-g/day increment of energy-
adjusted total DF was associated with a 14% decrease in risk of
coronary events and a 27% decrease in risk of coronary death.
However, in the only randomised clinical trial designed to
examine whether increased intake of DF reduces the risk of
myocardial infarction, the DART study,29 patients with existing
coronary heart disease advised to increase DF did not have lower
reinfarction rates over a 2-year period. Furthermore, DF advice
had no clear effect on coronary or all-cause mortality after
longer follow-up.30 Most likely, as assessed in prospective
studies,28 DF intake with the usual diet is a marker of healthy
food choices with an overall cardiovascular benefit, whereas
changing the diet to increase DF at late stages, when clinical
consequences of atherosclerosis have developed, may not be
protective, as has been shown in a similar situation for
antioxidant supplements as opposed to the antioxidant content
of the habitual diet.31 Indeed, a plant-based diet is rich in both
fibre and antioxidants. At any rate, increasing DF during
3 months by older individuals at high cardiovascular risk has
measurable beneficial effects on several risk factors.
Reduced adiposity, particularly in the highest category of DF
intake (tables 4 and 5), was observed in the present study. Large
prospective studies have reported that consumption of DF is
inversely associated with weight.32–34 A high intake of DF may
assist weight loss because of the incomplete digestion and
absorption of energy from this type of carbohydrate and the
bulky nature of high-fibre foods, with increased demands on
chewing and subsequent distension and delayed emptying of
the stomach, promoting satiety and thus curtailing energy
intake.25 26 35 The present results further support a beneficial role
of fibre-rich diets on weight control.
Increasing DF intake was associated with significant blood
pressure lowering in those mostly hypertensive participants.
Consistently, large prospective studies have reported that
increased DF was associated with lower risk of hypertension36
or lower self-reported blood pressure.37 A meta-analysis of
clinical studies of fibre supplementation12 also supports an
inverse association between fibre and blood pressure.
Accordingly, an increase in DF has been recommended by the
Table 3 Subjects’ characteristics and energy and nutrient intake according to quintiles of energy-adjusted dietary fibre intake at 3 months
Variables
Quintiles of energy-adjusted total fibre intake at baseline
p ValueQ1 Q2 Q3 Q4 Q5
N 144 146 143 143 145
Dietary fibre intake, g/d (median) (16 (14) 16.1–19.9 (18) 20.0–21.9 (21) 22.0–25.9 (23) >26.0 (29)
Age, years 68.7 (5.6) 69.3 (6.0) 68.4 (6.5) 68.9 (6.0) 69.2 (7.6) 0.667
Sex, men 60 77 62 64 64 0.609
Smokers, n (%) 27 (19) 26 (18) 24 (17) 17 (12) 28 (19) 0.733
Diabetes, n (%) 79 (55) 95 (65) 77 (54) 75 (52) 85 (59) 0.470
Hypertension, n (%) 125 (87) 130 (89) 111 (78) 108 (76) 112 (77) 0.294
Dyslipidaemia, n (%) 105 (73) 100 (69) 88 (62) 107 (75) 94 (65) 0.126
Body mass index, kg/m2 29.6 (4.0) 30.0 (4.5) 30.0 (4.5) 29.7 (4.0) 29.3 (3.9) 0.608
Waist circumference, cm 101 (10) 101 (12) 100 (11) 99 (13) 98 (10) 0.174
Energy, kcal/d 2059 (590) 2324 (520) 2538 (598) 2824 (724) 3065 (886) ,0.001
Protein, % En 17.6 (3.8) 17.2 (2.9) 16.9 (3.4) 16.6 (2.9) 16.8 (2.8) 0.043
Carbohydrate,% En 40.6 (8.5) 40.3 (7.6) 41.5 (6.9) 43.7 (6.8) 45.2 (6.8) ,0.001
Fat, % En 38.3 (7.9) 39.7 (7.3) 38.9 (7.2) 37.4 (6.1) 35.8 (6.1) ,0.001
MUFA 18.8 (5.0) 19.8 (2.5) 19.3 (4.6) 18.3 (4.1) 16.9 (3.8) ,0.001
PUFA 5.8 (2.1) 6.2 (1.8) 6.2 (2.2) 6.0 (1.8) 6.3 (2.7) 0.215
SFA 10.7 (2.7) 10.4 (2.5) 10.1 (2.2) 9.8 (2.1) 9.6 (2.4) ,0.001
Virgin olive oil, g/d 13.8 (20.9) 18.8 (22.8) 19.5 (23.1) 24.1 (25.4) 20.0 (23.4) 0.010
Alcohol, g/d 11.8 (22.7) 9.9 (16.7) 10.8 (16.8) 9.1 (13.5) 9.2 (11.7) 0.754
Low physical activity, n (%){ 47 (34) 45 (32) 46 (33) 35 (25) 32 (23) 0.155
Abbreviations as in table 2.
Values are means (standard deviations) unless otherwise stated.
*p Value for linear trend by ANOVA or chi-square test.
{Lowest tertile.
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World Health Organization as a safe and practical approach to
cardiovascular risk reduction in hypertensive populations.38
Participants who increased DF intake also showed a reduction
in fasting glucose levels, extending previous observations of the
favourable effects of a diet with abundant fibre-rich foods,
particularly whole grain, bran and germ intake, on the risk of
type 2 diabetes.9–11 39 40 Dietary fibre reduces the glycaemic index
of foods, thereby attenuating insulin responses and enhancing
insulin sensitivity,41 42 to which associated weight loss is likely
to contribute.
Structural fibre is insoluble, whereas natural gel-forming
fibres are soluble,2 and increasing consumption of this particular
variety of DF has a modest cholesterol-lowering effect that is
attributable to interference with intestinal bile acid absorption
and enhancement of faecal cholesterol excretion, although other
mechanisms can be operative.42 Thus, increasing soluble fibre
intake by 1 g/day is associated with a mean reduction in serum
LDL cholesterol level of about 2 mg/dl (0.052 mmol/l), accord-
ing to a meta-analysis of randomised trials of soluble fibre
supplementation.13 In support of these evidences, the present
study shows a significant 28.06 mg/dl LDL cholesterol decrease
between extreme quintiles of soluble fibre intake.
As atherosclerosis is considered a low-grade inflammatory
disease,43 the relationship between DF intake and serum
inflammatory markers has also been evaluated in epidemiolo-
gical and clinical studies, as reviewed.25–27 Results from recent
epidemiological studies have consistently shown an inverse
association between DF intake and plasma CRP levels.44–47 In a
recent study, both increasing fibre intake by about 30 g/day
from a diet naturally rich in fibre or from a supplement reduced
levels of CRP.48 Thus, it was not surprising that a nearly 1 mg/L
reduction in CRP levels was observed in the upper quintile of
energy-adjusted DF intake ((26 g/day), after adjustment for
sex, age, BMI and relevant lifestyle characteristics. However, no
changes were observed in other inflammatory biomarkers. The
mechanisms of change in CRP levels as a result of DF intake are
still largely unknown. Possibilities include DF slowing absorp-
tion of glucose, fibre-rich meal modulation of cytokine
responses blunting oxidative stress and inflammation, and
production of anti-inflammatory cytokines by gut flora exposed
to fibre.26 27
The present study has limitations. As no biomarker of DF
intake is available, FFQ data were the only source of
information on food consumption, including DF. Food fre-
quency questionnaires are known to contain measurement
errors, a reason why energy intake was included as a covariate in
the models to achieve the equivalent of an isoenergetic diet and
thus overcome this problem. At any rate, measurement error
Table 4 Three-month changes in risk factors by quintiles of change in dietary fibre intake
Variable changes
Quintiles of change in dietary fibre intake
Q1 Q2 Q3 Q4 Q5 p Value* p Value**
Fibre intake, range (g/d) ,22.5 22.5 to 0.2 0.2 to 1.8 1.8 to 5.3 .5.3
Fibre intake, median (g/d) 25.7 21.3 0.3 2.6 8.3
N 122 123 123 122 123
Weight, kg 0.02 20.19 20.23 20.38 20.90 ,0.001 0.001
Waist circumference, cm 0.74 20.17 20.83 21.27 21.90 ,0.001 ,0.001
Systolic BP, mmHg 20.19 22.67 22.95 22.43 29.08 ,0.001 ,0.001
Diastolic BP, mmHg 21.25 21.33 22.04 22.01 24.76 0.002 0.005
Fasting glucose, mg/dl 5.72 1.84 23.56 21.65 27.67 0.05 0.04
Fasting insulin, pmol/l 20.53 0.51 20.68 20.52 20.77 0.81 0.76
Total cholesterol, mg/dl 0.94 22.75 0.95 25.52 28.78 0.14 0.19
LDL cholesterol, mg/dl 21.66 22.15 23.77 25.09 28.63 0.14 0.14
HDL cholesterol, mg/dl 1.29 0.81 1.46 1.51 2.32 0.07 0.02
Triglycerides, mg/dl 25.09 24.20 0.70 22.23 23.62 0.80 0.70
C-reactive protein, mg/l 20.02 20.03 20.18 20.21 21.01 0.07 0.04
Interleukin-6, pg/ml 20.46 21.18 0.21 20.65 20.69 0.90 0.88
ICAM-1, ng/ml 214.6 227.1 239.6 223.3 222.6 0.81 0.82
VCAM-1, ng/ml 221 217 22 2117 277 0.19 0.23
BP, blood pressure; ICAM, intercellular adhesion molecule; VCAM, vascular cell adhesion molecule.
*p Value for linear trend adjusted for age, gender and energy intake.
**Additionally adjusted for intervention group and baseline body mass index, smoking, alcohol intake and physical activity.
Table 5 Mean changes (95% confidence intervals) and mean differences (95% confidence intervals) in changes in adiposity, blood pressure and other
risk factors between the lowest (Q1) and the highest (Q5) quintile of changes in total dietary fibre intake
Variable changes
Extremes of changes in dietary fibre intake
p Value**Q1 Q5 Change Q5 versus Q1*
Weight, kg 0.02 (20.36 to 0.32) 20.90 (21.40 to 20.42) 20.92 (21.52 to 20.33) 0.002
Waist circumference, cm 0.74 (20.20 to 1.68) 21.90 (23.18 to 20.60) 22.63 (24.20 to 21.07) 0.001
Systolic blood pressure, mmHg 20.19 (23.41 to 3.03) 29.08(212.21 to 25.95) 28.89 (213.37 to 24.41) ,0.001
Diastolic blood pressure, mmHg 21.25 (22.70 to 0.21) 24.76 (26.46 to 23.08) 23.52 (25.73 to 21.31) 0.002
Fasting glucose, mg/dl 5.72 (0.64 to 10.79) 27.67 (211.84 to 23.50) 213.39 (219.86 to 26.93) ,0.001
Total cholesterol, mg/dl 0.94 (25.24 to 7.12) 28.78 (214.30 to 23.27) 29.73 (217.96 to 21.49) 0.021
LDL cholesterol, mg/dl 21.66 (26.96 to 3.64) 28.63 (214.26 to 23.00) 27.90 (214.96 to 0.72) 0.075
HDL cholesterol, mg/dl 1.29 (0.08 to 2.52) 2.32 (1.08 to 3.57) 1.03 (20.70 to 2.76) 0.242
C-reactive protein, mg/l 20.02 (20.51 to 0.48) 21.01 (21.53 to 20.49) 21.08 (21.80 to 20.48) 0.004
*Differences between baseline and 3-month follow-up evaluation.
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most likely would have introduced non-differential misclassifi-
cation, and the implications for the results of this error would
have been to bias the estimates towards the null. The duration
of follow-up lasting only 3 months cannot be considered a
major limitation, because the effects of dietary interventions on
risk factors do not need a long induction period.49 The study also
has strengths, such as reproducing real-life conditions with
home-prepared foods in free-living individuals, as in usual
clinical practice. Other strengths are the high response and low
drop-out rates, which can be partly explained because partici-
pants belonged to a Mediterranean culture in which people are
accustomed to using olive oil and nuts and enjoy eating fibre-
rich vegetables, fruits and legumes, and the supplemental foods
were provided at no cost.
In summary, the results of this study show that an increase in
DF intake achieved with natural foods in the setting of a
Mediterranean-style diet can reduce cardiovascular risk factors.
Except for subjects in the highest 20% of DF intake, the effects
on each individual risk factor were modest but, taken together,
they suggest that increasing DF consumption may be instru-
mental in modifying the population cardiovascular risk profile,
therefore preventing or delaying future cardiovascular events.
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